GLP-1 (Liraglutide)

Product Details- GLP-1 (Liraglutide) Peptide

Liraglutide is the synthetic version of a naturally occurring peptide hormone, GLP-1 (Glucagon-Like Peptide). The GLP-1 is naturally secreted with the potential to influence the working patterns of insulin secretion in research subjects. Similarly, the Liraglutide peptide is synthetically designed to mimic the mechanism of action of GLP-1 peptide in research models during clinical research. 

Influencing the patterns of insulin secretion associated with maintaining blood glucose levels, regulating weight management, and controlling appetite in research models during clinical investigation. It has also been studied that it may affect the patterns linked with gut health and chronic type-2 diabetes in research subjects. 

How Does GLP-1 (Liraglutide) Peptide Work? 

During preclinical research, it has been observed that the working mechanism of Liraglutide is similar to that of GLP-1 peptide in research models. It has also been studied that it has the potential to affect the working patterns linked with insulin production. 

Regulated insulin secretion may lead to various changes associated with weight loss management and balanced sugar levels in research subjects. Similarly, it may also affect the biomarkers associated with food digestion and stomach emptying in test subjects during preclinical research. 

Properties of GLP-1 (Liraglutide) Peptide

• Molecular Formula: 
• Synonym: Liraglutide, 204656-20-2, NN2211, victoza, Liraglutida, NN-2211, Liraglutidum, NN 2211 
• Molecular weight: 3751 g/mol
• CAS Number: 204656-20-2
• PubChem CID: 16134956 
• Shelf Life: 36 months

Potential Benefits of GLP-1 (Liraglutide) Peptide

The potential benefits of GLP-1 (Liraglutide) peptide in research subjects are as follows:

• Influences the Patterns of Type-2 Diabetes

In preclinical research on non-human subjects, it is observed that GLP-1 (Liraglutide) may affect the patterns linked with type-2 diabetes. The patterns of type-2 diabetes may be affected by stimulating insulin secretion in response to glucose levels in research subjects. Insulin secretion may maintain blood glucose levels and help the subjects maintain their sugar levels during the research investigation. Such maintained levels of sugar may address the issue of type-2 diabetes in test models. [1]

• Maintains Weight Management 

Another potential benefit of the GLP-1 (Liraglutide) peptide is maintaining the patterns of weight management in research models. To affect this mechanism, GLP-1 may influence the biomarkers linked with blood sugar control in research subjects. Such biomarkers may reduce the conversion of extra glucose into glycogen and fats, maintaining weight management in research models. [2]   

• Regulates Appetite

Research studies have observed the potential of GLP-1 (Liraglutide) peptide to regulate appetite in research models. To regulate appetite, the GLP-1 (Liraglutide) peptide may influence insulin secretion patterns in subjects, improving insulin secretion. In return, the improved insulin level may affect the working patterns of the hypothalamus, which is responsible for regulating appetite in research models. [3]

• Maintains Sugar Levels (Glucose Levels)

Some studies on animals have also found the potential of GLP-1 (Liraglutide) peptide to maintain sugar levels in research models. This potential may be exhibited when GLP-1 (Liraglutide) peptide influences the secretion patterns of insulin, increasing its production. The improved insulin level may maintain the patterns associated with sugar levels in test subjects. [4] 

Why Choose BehemothLabz to Buy GLP-1 (Liraglutide) Peptide

Make the smart choice today by choosing us! Order GLP-1 (Liraglutide) peptide now and begin your research journey. 

For the past ten years, we have been among the few vendors in the market offering various products, including GLP-1 peptide, for sale. Our products are particularly designed to meet industrial standards and researchers’ needs and demands. Other than that, we have more than one thousand positive customer reviews, indicating our customers’ trust in us. 

Furthermore, we are among a few online vendors offering national and international shipping mechanisms. Fortunately, our shipping prices are very reasonable and within your buying range. We also provide 24/7 customer satisfaction service, addressing each query about our loyal customers. 

Such a place that blends these qualities can’t be found anywhere else! So order our GLP-1 (Liraglutide) peptide now to support your research investigation. 

Disclaimer: Our products are for research and laboratory purposes only. The peptides have not yet been approved by the Food and Drug Administration Department and the World Anti-Doping Agency; therefore, they are not permitted for human consumption. 

Frequently Asked Questions (FAQS)

What are the risks of Liraglutide in research settings?

Some potential risks of the GLP-1 (Liraglutide) peptide in research settings may include injection site reactions, nausea, and vomiting. Furthermore, it may negatively influence the gastrointestinal tract of research subjects. 

What is the best place to buy GLP-1 (Liraglutide) Peptide? 

The best place to buy GLP-1 (Liraglutide) peptide is BehemothLabz. We offer 99.9% pure GLP-1 peptide for sale. Our peptides are specially designed to meet industrial standards and researchers’ requirements. Therefore, they have the maximum chance of giving accurate research results. 

How does GLP-1 help research models lose weight in preclinical research? 

The weight-related responses have been observed in non-human subjects during clinical trials in research settings. These responses may occur through effectively utilising glucose and food digestion in the research subject. 

Does Liraglutide cause hair loss in research subjects? 

Hair loss is not explicitly highlighted as a drawback of Liraglutide peptide during research investigation in research models. 

Is Liraglutide the same as GLP-1?

Yes, Liraglutide is the synthetic version of the naturally occurring GLP-1 peptide hormone. It is designed to mimic the effects of GLP-1 peptide during clinical research in test models. 

References

1. Russell-Jones, David. “Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue.” Molecular and cellular endocrinology 297.1-2 (2009): 137-140.
2. Vilsbøll, Tina. “Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus.” Expert opinion on investigational drugs 16.2 (2007): 231-237.
3. Madsbad, Sten. “Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)–preclinical and clinical results.” Best practice & research clinical endocrinology & metabolism 23.4 (2009): 463-477.
4. Marre, M. U. S. T. A. F. A., et al. “Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD‐1 SU).” Diabetic Medicine 26.3 (2009): 268-278.

Strength	3mg, 5mg

1st Party COA

3rd Party COA